Related Experiment Video
Updated: Jan 18, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Simultaneous optimization of multiple plans within one treatment course with dosimetric pathfinding for temporally
Julius Arnold1,2,3, Chengchen Zhu1, Gian Guyer1
1Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Background:
Radiotherapy workflows conventionally deliver one treatment plan multiple times throughout the treatment course. Non-coplanar techniques with beam angle optimization or dosimetrically optimized pathfinding (DOP) exploit additional degrees of freedom to improve spatial conformality of the dose distribution compared to widely used techniques like volumetric-modulated arc therapy (VMAT). The temporal dimension of dose delivery can be exploited using multiple plans (sub-plans) within one treatment course. For instance, temporally feathered radiation therapy (TFRT) uses iso-curative sub-plans to deliver an alternance of higher and lower doses compared to a single plan to selected organs-at-risk (OARs), facilitating the dynamic recovery process of healthy tissues.
Purpose:
This study presents a simultaneous optimization framework based on direct aperture optimization with or without DOP to optimize multiple coplanar or non-coplanar sub-plans within one treatment course and demonstrates its use for TFRT planning.
Methods:
The goal of the framework was to minimize an objective function consisting of weighted upper or lower dose-volume, generalized equivalent uniform dose, and normal tissue objectives set on the dose distribution of each sub-plan or the combined total plan. Reference VMAT and dynamic collimator trajectory radiotherapy (colli-DTRT) single plans were created and used to derive the objectives for TFRT planning. The TFRT high-to-low dose modulation was integrated into the objective list and systematically investigated for a digital academic phantom using three variations ("soft", "medium", "hard"). Additionally, a "super-soft" variation used the same objectives for all five sub-plans (i.e., no high-to-low dose modulation). Furthermore, "medium" TFRT sub-plans with colli-DTRT were created for three more complex clinically motivated head and neck cases.
Results:
For the phantom, the sub-plans were iso-curative with target D98% within 1.6% of the reference plans. High-to-low OAR dose modulation was achieved with median Dmean differences between high and low dose fractions of 2.7% of the prescription dose (soft), 3.3% (medium), and 4.4% (hard) for VMAT. Median OAR Dmean differences were 2.8% of the prescription dose (soft), 6.3% (medium), and 6.1% (hard) for colli-DTRT. The dose distributions of the total plans had higher homogeneity indices (HI = D98%/D2%) compared to the reference plans. Lower OAR Dmean were achieved for the soft, medium, and hard TFRT variation in the total plans compared to the reference plan. However, in the super-soft variation only five of the 10 feathered OARs showed this reduction. For the three clinically motivated cases with colli-DTRT, median OAR Dmean differences between the high and low dose fractions were 3.5%, 4.2%, and 7.5% of the prescription dose. The total plans' dose distributions had higher HIs compared to their respective reference plans and lower or equal Dmean for all feathered OARs except for pharynx in one case.
Conclusion:
A framework for the simultaneous optimization of multiple coplanar or non-coplanar sub-plans within one treatment course was developed. Simultaneous optimization was investigated with a phantom and three clinically motivated cases for TFRT planning. OAR dose modulation in the sub-plans was achieved while increasing target homogeneity and reducing OAR doses in the dose distribution of the total plans compared to the reference plans.
Related Concept Videos
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

